Scientists Discover New Path to Treat Huntington's Disease

For the first time in decades, scientists have found a surprisingly simple way to stop neurodegeneration in Huntington's disease, a fatal inherited brain condition that has resisted every treatment attempt.

Researchers at Lawrence Berkeley National Laboratory discovered that DNA breaks throughout the brain drive the disease's devastating symptoms. When they treated mice with an antioxidant called XJB-5-131, it repaired the damage and reversed neurodegeneration completely.

"Despite years of work worldwide, there's no cure for Huntington's, and only limited experimental treatments," said Aris Polyzos, a biochemist at Berkeley Lab who co-led the study. The team's findings, published in Nature Communications, reveal why this single gene mutation causes such complex destruction in the brain.

Huntington's disease occurs when people inherit a mutated gene containing extra repeating sequences. As patients age, neurons in certain brain regions die off, leading to cognitive and physical decline. Scientists previously focused on stopping these genetic repeats from expanding, but those complicated interventions never helped real patients.

The Berkeley Lab team took a different approach. After ten years studying how brain cells use energy in Huntington's patients, they noticed something crucial: support cells in the brain switch from using glucose to fatty acids for fuel. This metabolic shift creates harmful molecules called reactive oxygen species that break DNA strands.

The antioxidant XJB-5-131 crosses the blood-brain barrier and targets the cell's powerhouses, neutralizing these damaging molecules before they break DNA. Remarkably, this protection worked even without editing genes or stopping the mutation from expanding.

"I believe we're opening the door to a new way to treat Huntington's patients," said senior researcher Cynthia McMurray, who spent decades studying the disease. "Clinical agents already exist for humans that are known to change these breaks."

Why This Inspires

The elegance of this discovery lies in its simplicity. While other researchers pursued complex genetic interventions that failed in clinical trials, the Berkeley team found that addressing DNA damage directly could halt the disease's progression.

Antioxidant treatments for humans already exist and have known safety profiles. This means the pathway from laboratory discovery to potential clinical trials could be remarkably swift compared to developing entirely new drugs or gene therapies.

The research represents a fundamental shift in understanding how inherited diseases cause damage. Rather than focusing solely on the mutated gene itself, scientists can now target the downstream effects that actually kill neurons.

For families living with Huntington's disease, knowing when symptoms will start based on genetic repeats has been a cruel certainty with no solutions. This discovery offers the first real possibility of intervention that could work in actual patients, not just in theory.

The next step is confirming these findings protect human neurons, which would pave the way for clinical trials and potentially the first effective treatment for a disease that has stumped researchers for generations.